Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vertex Pharma reports 4th-quarter profit as sales of hepatitis C drug Incivek reach $456.8M
Vertex Pharma reports 4th-quarter profit as sales of hepatitis C drug Incivek reach $456.8M
Vertex Pharma reports 4th-quarter profit as sales of hepatitis C drug Incivek reach $456.8M
Submitted by
admin
on February 3, 2012 - 9:46am
Source:
Yahoo/AP
News Tags:
Vertex
hepatitis C
Incivek
earnings
Headline:
Vertex Pharma reports 4th-quarter profit as sales of hepatitis C drug Incivek reach $456.8M
Do Not Allow Advertisers to Use My Personal information
